The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKainos Group Regulatory News (KNOS)

Share Price Information for Kainos Group (KNOS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 964.00
Bid: 964.00
Ask: 966.00
Change: 14.00 (1.47%)
Spread: 2.00 (0.207%)
Open: 946.00
High: 966.00
Low: 935.00
Prev. Close: 950.00
KNOS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Total Voting Rights

4 Feb 2019 16:11

RNS Number : 0262P
Kainos Group plc
04 February 2019
 

4 February 2019

Kainos Group plc

 

("Kainos" or the "Company") 

Total Voting Rights

Pursuant to DTR 5.6.1 the Company announces that as at 1 February 2019, the total number of ordinary shares in issue now stands at 120,967,834 each with voting rights. There are no shares held in treasury.

 

The above figure (120,967,834) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the Company under the FCA's Disclosure and Transparency Rules.

 

Kainos Group Limited Legal Entity Identifier: 213800H2PQMIF3OVZY47 

Classification: 2.5 - Total number of voting rights and capital

 

Ends

 

For further information, please contact:

 

Kainos via FTI Consulting LLP

Brendan Mooney, Chief Executive Officer

Richard McCann, Chief Financial Officer

 

Investec Bank plc +44 20 7597 5970

Patrick Robb / Sebastian Lawrence

 

Canaccord Genuity +44 20 7523 4606

Simon Bridges / Emma Gabriel

 

FTI Consulting LLP +44 20 3727 1000

Matt Dixon / Harry Staight

 

About Kainos

Kainos Group plc is a UK-based provider of Digital Services and Digital Platforms.

 

The Group's Digital Services include full lifecycle development and support of customised Digital Services for government and commercial customers. Kainos is also the leading European partner for Workday Inc. ('Workday') responsible for implementing Workday's innovative Software-as-a-Service (SaaS) platform for enterprise and, now, government customers.

 

The Group's Digital Platforms comprise specialised digital products in the mobile healthcare and automated testing arenas. Smart is an automated testing platform for Workday customers; Evolve Electronic Medical Records ('EMR') is the market leading product for the digitisation of patient notes in the Acute sector of the NHS; and Evolve Integrated Care ('IC') is a SaaS-based integrated care platform for the NHS and international healthcare providers.

 

Kainos has over 1,300 people across eleven offices in Europe and the USA, working interchangeably across its Services and Platforms divisions.

 

Kainos is listed on the London Stock Exchange (LSE: KNOS). For further information, please visit www.kainos.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TVRQZLFBKLFFBBB
Date   Source Headline
18th Oct 20227:00 amRNSUpdate on office development & partial site sale
3rd Oct 202211:14 amRNSTotal Voting Rights
28th Sep 20222:04 pmRNSResult of AGM
1st Sep 20222:05 pmRNSTotal Voting Rights
1st Sep 20227:00 amRNSTrading Statement
24th Aug 20222:07 pmRNSNotice of AGM
1st Aug 202211:12 amRNSTotal Voting Rights
29th Jul 202210:12 amRNSPublication of Annual Report 2022
29th Jul 20227:00 amRNSWorkday Partner Status Update
1st Jul 20225:36 pmRNSDirector Share Awards
29th Jun 202210:15 amRNSDirector/PDMR Shareholding
20th Jun 20225:22 pmRNSHolding(s) in Company
1st Jun 202211:42 amRNSTotal Voting Rights
23rd May 20227:00 amRNSFull Year Results
4th May 202210:56 amRNSTotal Voting Rights
19th Apr 20227:00 amRNSTrading Statement
31st Mar 20222:33 pmRNSTotal Voting Rights
1st Mar 20221:21 pmRNSTotal Voting Rights
21st Feb 20227:00 amRNSPlanalyse acquisition strengthens Kainos
1st Feb 202212:40 pmRNSTotal Voting Rights
11th Jan 20227:00 amRNSKainos acquires Blackline Group
10th Jan 20224:14 pmRNSDirector/PDMR Shareholding
31st Dec 202110:26 amRNSTotal Voting Rights
13th Dec 20213:26 pmRNSDirector/PDMR Shareholding
2nd Dec 20213:23 pmRNSTotal Voting Rights
24th Nov 20211:11 pmRNSPerson Closely Associated shareholdings
18th Nov 20213:34 pmRNSDirector/PDMR Shareholding
15th Nov 20217:00 amRNSKainos Half-year Report
1st Nov 20215:15 pmRNSTotal Voting Rights
1st Oct 202110:28 amRNSTotal Voting Rights
29th Sep 20213:33 pmRNSHolding(s) in Company
29th Sep 20211:18 pmRNSDirector/PDMR Shareholding
23rd Sep 20215:33 pmRNSAGM Results
23rd Sep 20215:30 pmRNSDirectorate Change
8th Sep 20213:15 pmRNSDirector/PDMR Shareholding
2nd Sep 202110:20 amRNSDirector/PDMR Shareholding
1st Sep 20215:38 pmRNSTotal Voting Rights
1st Sep 20217:00 amRNSAcquisition
1st Sep 20217:00 amRNSTrading Statement
25th Aug 20212:28 pmRNSDirector/PDMR Shareholding
18th Aug 202111:28 amRNSNotice of AGM
12th Aug 20212:05 pmRNSDirector/PDMR Shareholding
10th Aug 202112:41 pmRNSChange of Auditor
2nd Aug 202111:57 amRNSTotal Voting Rights
30th Jul 202112:25 pmRNSAnnual Financial Report
9th Jul 20216:31 pmRNSDirector/PDMR Shareholding
1st Jul 20214:35 pmRNSTotal Voting Rights
29th Jun 20213:58 pmRNSDirector/PDMR Shareholding
1st Jun 20217:00 amRNSAcquisition
24th May 20217:00 amRNSKainos Final Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.